A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.

Sleep Med Rev

Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA. Electronic address:

Published: June 2014

Pregabalin is approved for the treatment of a variety of clinical conditions and its analgesic, anxiolytic and anticonvulsant properties are well documented. Pregabalin's effects on sleep, however, are less well known. This review summarizes the published data on the effects of pregabalin on sleep disturbance associated with neuropathic pain, fibromyalgia, restless legs syndrome, partial onset seizures and general anxiety disorder. The data demonstrate that pregabalin has a positive benefit on sleep disturbance associated with several different clinical conditions. Polysomnographic data reveal that pregabalin primarily affects sleep maintenance. The evidence indicates that pregabalin has a direct effect on sleep that is distinct from its analgesic, anxiolytic and anticonvulsant effects.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.smrv.2013.07.005DOI Listing

Publication Analysis

Top Keywords

pregabalin sleep
12
sleep disturbance
12
clinical conditions
12
effects pregabalin
8
analgesic anxiolytic
8
anxiolytic anticonvulsant
8
disturbance associated
8
pregabalin
6
sleep
6
review effects
4

Similar Publications

Updates in nonhormonal therapy for perimenopausal and menopausal symptoms.

Curr Opin Obstet Gynecol

January 2025

Division of Complex Family Planning, Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, California, USA.

Purpose Of Review: Perimenopausal and menopausal symptoms are common and may significantly impact quality of life. Menopausal hormone therapy is the most effective treatment but may not be appropriate in all cases. Nonhormonal alternatives range from lifestyle changes and dietary supplements to medical interventions and prescription therapies.

View Article and Find Full Text PDF

Fibromyalgia: do I tackle you with pharmacological treatments?

Pain Rep

February 2025

Pain Department, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Cité University, INSERM U987, Paris, France.

Pharmacological approaches are frequently proposed in fibromyalgia, based on different rationale. Some treatments are proposed to alleviate symptoms, mainly pain, fatigue, and sleep disorder. Other treatments are proposed according to pathophysiological mechanisms, especially central sensitization and abnormal pain modulation.

View Article and Find Full Text PDF

Introduction Fibromyalgia is a chronic pain disorder characterized by widespread pain, fatigue, and sleep disturbances. The purpose of this study was to compare how well duloxetine, pregabalin, and milnacipran worked for fibromyalgia patients in terms of pain management, quality of life, and sleep quality. Methodology A prospective cohort research study with 193 fibromyalgia patients was carried out at the Abbas Institute of Medical Sciences, Muzaffarabad, Pakistan.

View Article and Find Full Text PDF

Efficacy of Higher-Voltage Long-Duration Pulsed Radiofrequency for Spinal Zoster-Associated Pain: A Randomized Controlled Trial.

Pain Physician

December 2024

Department of Pain Management, West China Hospital/West China Tianfu Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Article Synopsis
  • The study evaluates the safety and effectiveness of a higher-voltage long-duration pulsed radiofrequency (HL-PRF) treatment for managing zoster-associated pain (ZAP) compared to standard treatment.
  • Patients in Group A received gradually increased voltage up to 100 V, while Group B maintained a steady 65 V throughout.
  • Results focused on pain levels, emotional well-being, and quality of life over 12 weeks, with an aim to address high recurrence rates associated with the existing methods.
View Article and Find Full Text PDF
Article Synopsis
  • Pulse radiofrequency (PRF) combined with transverse abdominal plane (TAP) block was studied to improve pain relief in patients suffering from herpes zoster (HZ), as some patients still experience pain despite PRF treatment.
  • The study involved 137 HZ patients divided into two groups: one receiving TAP block and the other receiving normal saline, with pain and quality of life assessed at multiple follow-up points.
  • Results indicated the TAP group experienced significantly less pain, improved sleep quality, and a better quality of life compared to the normal saline group at various follow-up intervals, alongside a reduction in the use of pain medications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!